AngioDynamics Q1 FY2024 revenue $78.7M, pro-forma +5.7%; adj. loss $(0.12)/share

ANGIODYNAMICS INC

2024-Q1 EPS reported $1.15 revenue$78,679,000

Net sales $78.7M (ex-Dialysis/BioSentry +5.7% YoY); Med Tech +13.3% on Auryon +25.7%, NanoKnife +34.5%.
GAAP net income $45.9M ($1.15 EPS) includes $47.8M gain from Dialysis/BioSentry sale; adjusted loss $(0.12)/share.
Completed sale of Dialysis & BioSentry to Merit Medical for $100M cash; proceeds used to extinguish debt.
Reaffirmed FY2024 outlook: net sales $328-333M, gross margin ~50-52%, adjusted EPS loss $(0.28)-(0.34).
Cash & equivalents $57.6M at Aug 31, 2023, up from $44.6M at May 31, 2023; debt-free post-divestiture.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ANGIODYNAMICS INC reported the first quarter of fiscal year 2024, which ended August 31, 2023 results: revenue $78.7 million, net income $45.9 million, EPS $1.15. Guidance reaffirmed.

Period: the first quarter of fiscal year 2024, which ended August 31, 2023
Revenue: $78.7 million
Net income: $45.9 million
EPS: $1.15
Guidance: reaffirmed
Result: reported results

Exact text from the filing

795-1408 AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance Fiscal Year 2024 First Quarter Highlights • Net sales of $78.7 million as reported o Includes $0.7 million of Dialysis and BioSentry Biopsy Tract Sealant System sales o Net sales increased 5.7% on a pro-forma basis when excluding Dialysis and

View on SEC.gov

Browse all earnings releases →

ANGIODYNAMICS INC filing history →

Source: SEC EDGAR

accession 0001140361-23-046804

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.